1. Home
  2. WIW vs BVS Comparison

WIW vs BVS Comparison

Compare WIW & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Opportunities & Income Fund

WIW

Western Asset Inflation-Linked Opportunities & Income Fund

HOLD

Current Price

$8.64

Market Cap

529.9M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$8.43

Market Cap

482.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIW
BVS
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
482.9M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
WIW
BVS
Price
$8.64
$8.43
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.33
AVG Volume (30 Days)
252.0K
249.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.14%
N/A
EPS Growth
N/A
79.12
EPS
N/A
0.12
Revenue
N/A
$573,280,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.78
P/E Ratio
N/A
$73.29
Revenue Growth
N/A
11.89
52 Week Low
$8.33
$5.81
52 Week High
$9.03
$11.25

Technical Indicators

Market Signals
Indicator
WIW
BVS
Relative Strength Index (RSI) 44.34 54.31
Support Level $8.49 $7.04
Resistance Level $8.84 $9.01
Average True Range (ATR) 0.07 0.32
MACD -0.01 -0.01
Stochastic Oscillator 24.44 51.01

Price Performance

Historical Comparison
WIW
BVS

About WIW Western Asset Inflation-Linked Opportunities & Income Fund

Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income. Capital appreciation, when consistent with current income, is a secondary investment objective. The fund operates as a single operating segment, which is an investment portfolio.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: